What is the role of uPAR in the diagnosis and prognosis of ovarian cancer?

David A. Fishman, MD
Gynecologic Oncology
UPAR is urokinase-type plasminogen activator receptor. Its truncated forms have been evaluated with regard to differentiating malignant from benign adnexal masses and therefore as a potential biomarker (characteristic used in screening, early diagnosis, prognosis, tracking treatment response or recurrence of disease) in ovarian cancer. Urokinase plasminogen activator (uPA) has been found to be involved in tumor angiogenesis, development, inflammation and metastasis.

Continue Learning about Ovarian Cancer

How Is Ovarian Cancer Diagnosed and Treated?
How Is Ovarian Cancer Diagnosed and Treated?
A mass on the ovary is usually detected through transvaginal ultrasound, but needs further testing before diagnosis, says Audra Moran. In this video s...
Read More
Can only older women get ovarian cancer?
Jumo HealthJumo Health
Ovarian cancer doesn’t just happen in older women. Younger women can also be affected.
More Answers
What factors affect the prognosis of ovarian cancer?
Honor Society of Nursing (STTI)Honor Society of Nursing (STTI)
Your age, your general health, and the stage of your tumor all affect prognosis in ovarian cancer. T...
More Answers
Where Are We with Early Detection for Ovarian Cancer?
Where Are We with Early Detection for Ovarian Cancer?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.